UCB PHARMA GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 45210
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1184
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 11127
 
 
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 6134
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
 
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 170
 
 
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
 
 
B26D CUTTING; DETAILS COMMON TO MACHINES FOR SEVERING, e.g. BY CUTTING, PERFORATING, PUNCHING, STAMPING-OUT 136

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0151,215 USE OF ROTIGOTINE FOR TREATING THE RESTLESS LEG SYNDROMEFeb 09, 17Jun 01, 17[A61K]
2017/0105,945 Transdermal Delivery System Containing RotigotineMay 20, 15Apr 20, 17[A61K]
2017/0079,932 Method for Adjusting the Release of Active Agent in a Transdermal Delivery systemMay 20, 15Mar 23, 17[A61K]
2015/0290,142 Multi-Day Patch for the Transdermal Administration of RotigotineNov 21, 13Oct 15, 15[A61K, B32B]
2014/0378,917 TRANSDERMAL THERAPEUTIC SYSTEM WITH A LOW TENDENCY TO SPONTANEOUSLY CRYSTALLIZEDec 28, 12Dec 25, 14[A61K]
2014/0128,377 METHODS OF TREATING REFRACTORY REPETITIVE SEIZURESJan 14, 14May 08, 14[A61K]
2010/0273,714 PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUSJun 15, 07Oct 28, 10[A61K, A61P]
2004/0048,779 Use of rotigotine for treating the restless leg syndromeMay 02, 03Mar 11, 04[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9630908 Process for preparing lacosamideAug 17, 15Apr 25, 17[C12P, C07C]
9446011 Anticonvulsant combination therapyMar 31, 15Sep 20, 16[A61K, B65D]
9364541 Pharmaceutical compositions comprising FesoterodineJul 02, 13Jun 14, 16[A61K, A01N]
9308183 Therapy for hyperexcitability disordersJun 29, 07Apr 12, 16[A61K, G01N]
9309215 Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereofApr 21, 14Apr 12, 16[A61K, C07D, C07C]
9186335 Hot melt TTS for administering rotigotineJul 29, 03Nov 17, 15[A61K]
9139513 Process for preparing lacosamideNov 09, 11Sep 22, 15[C12P, C07C]
9108900 Method of treating diseases that respond to therapy by dopamine or dopamine agonistsOct 25, 13Aug 18, 15[A61K, C07C]
9095557 Anticonvulsant combination therapyNov 14, 13Aug 04, 15[A61K]
9034914 Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresisMar 31, 14May 19, 15[A61K, C07D, A61N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0035,733 PHARMACEUTICAL COMPOSITION COMPRISING LACOSAMIDE AND LEVETIRACETAMAbandonedNov 28, 14Feb 09, 17[A61K]
2015/0104,507 FORMULATION OF LACOSAMIDEAbandonedOct 21, 14Apr 16, 15[A61K]
2014/0128,378 METHODS OF TREATING EPILEPTOGENESISAbandonedJan 14, 14May 08, 14[A61K]
2014/0066,515 METHODS FOR TREATING CHANNELOPATHIESAbandonedSep 10, 13Mar 06, 14[A61K]
8604076 Method for producing a pharmaceutical composition comprising rotigotineExpiredAug 21, 01Dec 10, 13[A61K, A01N]
2013/0251,813 FORMULATION OF LACOSAMIDEAbandonedDec 01, 11Sep 26, 13[A61K]
8536137 Methods for treating nucleoside-induced painExpiredOct 12, 09Sep 17, 13[A61K, A61P]
8338641 Method for treating atypical facial painExpiredJun 16, 10Dec 25, 12[C07C]
8283376 Use of substituted 2-aminotetralins for preventive treatment of parkinson's diseaseExpiredDec 23, 04Oct 09, 12[A61K]
2012/0225,119 THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONSAbandonedApr 09, 12Sep 06, 12[A61K, A61P]
2011/0288,106 ADENINE RECEPTOR LIGANDSAbandonedJun 29, 09Nov 24, 11[A61K, C07D, A61P]
8053476 Method for treating peripheral neuropathic painExpiredAug 21, 06Nov 08, 11[A61K, C07C]
8008351 Methods for prophylaxis or treatment of conditions associated with cortical spreading depressionExpiredApr 15, 05Aug 30, 11[A61K, A01N]
2011/0104,281 METHOD FOR TREATING PAIN USING A SUBSTITUTED 2-AMINOTETRALIN COMPOUNDAbandonedJan 05, 11May 05, 11[A61K, A61P]
2011/0082,211 METHOD FOR TREATING TINNITUS AUREUMAbandonedNov 15, 10Apr 07, 11[A61K, A61P]
7875652 Method and composition for treating pain or tinnitus aureumExpiredMar 19, 02Jan 25, 11[A61K]
7872041 Use of rotigotine for treating and preventing Parkinson's plus syndromeExpiredMar 22, 05Jan 18, 11[A61K, A61P]
7820857 Method for treating pain in trigeminal neuralgiaExpiredJun 09, 05Oct 26, 10[C07C]
2010/0260,716 COMPOUNDS FOR TREATING DEMYELINATION CONDITIONSAbandonedOct 23, 08Oct 14, 10[A61K, A61P]
2010/0256,179 COMBINATION THERAPY FOR PAIN IN PAINFUL DIABETIC NEUROPATHYAbandonedApr 01, 10Oct 07, 10[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.